carbidopa has been researched along with Melanoma in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Cichoń, T; Frackowiak-Wojtasek, B; Gasowska-Bajger, B; Koj, S; Smolarczyk, R; Szala, S; Wojtasek, H | 1 |
Amaro, F; Duarte, D; Fresco, P; Gonçalves, J; Oliveira, JC; Reguengo, H; Silva, D; Silva, I; Vale, N | 1 |
Guillén Climent, S; Monteagudo, C; Pinazo Canales, MI; Porcar Saura, S | 1 |
Gunder, M; Miller, S; Stewart, RM | 1 |
Meadows, GG; Pierson, HF | 1 |
Wick, MM | 2 |
Abdallah, RM; Desai, PR; Meadows, GG; Pierson, HF | 1 |
Coates, A; Gurney, H; Kefford, R | 1 |
9 other study(ies) available for carbidopa and Melanoma
Article | Year |
---|---|
Oxidation of carbidopa by tyrosinase and its effect on murine melanoma.
Topics: Animals; Antineoplastic Agents; Carbidopa; Cell Line, Tumor; Cyclization; Dihydroxyphenylalanine; Melanoma; Mice; Monophenol Monooxygenase; Oxidation-Reduction; Prodrugs | 2009 |
Carbidopa Alters Tryptophan Metabolism in Breast Cancer and Melanoma Cells Leading to the Formation of Indole-3-Acetonitrile, a Pro-Proliferative Metabolite.
Topics: Breast Neoplasms; Carbidopa; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography, High Pressure Liquid; Female; Humans; Indoles; Melanoma; Skin Neoplasms; Spectrometry, Mass, Electrospray Ionization; Tryptophan | 2019 |
Melanocytic Hyperactivation Simulating an Acral Lentiginous Melanoma in a Patient With Parkinson Disease Treated by Levodopa.
Topics: Aged; Antiparkinson Agents; Carbidopa; Diagnosis, Differential; Drug Combinations; Female; Humans; Hyperpigmentation; Levodopa; Melanins; Melanocytes; Melanoma; Parkinson Disease; Predictive Value of Tests; Skin; Skin Neoplasms; Skin Pigmentation; Treatment Outcome | 2021 |
Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
Topics: Adult; Aged; Carbidopa; Cysteinyldopa; Dihydroxyphenylalanine; Humans; Melanoma; Middle Aged; Parkinson Disease; Skin Neoplasms | 1983 |
Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
Topics: Animals; Antineoplastic Agents; Ascorbic Acid; Carbidopa; Cell Line; Diet; Drug Synergism; Drug Therapy, Combination; Female; Injections, Intraperitoneal; Levodopa; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1983 |
The chemotherapy of malignant melanoma.
Topics: Carbidopa; Cardiovascular Diseases; Dopamine; Drug Evaluation; Humans; Levodopa; Melanoma; Mitotic Index; Skin Neoplasms | 1983 |
Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy.
Topics: Animals; Carbidopa; Diet; Drug Evaluation, Preclinical; Female; Levodopa; Melanoma; Mice; Neoplasms, Experimental; Phenylalanine; Tyrosine | 1982 |
The use of L-dopa and carbidopa in metastatic malignant melanoma.
Topics: Carbidopa; Female; Humans; Levodopa; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Skin Neoplasms | 1991 |
Inhibition of transformation by levodopa-carbidopa in lymphocytes derived from patients with melanoma.
Topics: Carbidopa; Dopamine; Drug Combinations; Humans; Levodopa; Lymphocyte Activation; Melanoma; Osmolar Concentration; Phytohemagglutinins | 1987 |